<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

CNF 2024 - BIIB 021

產(chǎn)品貨號

Axon 1543 CAS [848695-25-0] MF C14H15ClN6OMW 318.76 Purity: 99% Soluble in DMSO Description Oral inhibitor of heat shock protein 90 (Hsp90) under clinical development References Certificates Categories Extra info B B?ll et al. Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF-κB and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell–Mediated Cytotoxicity. Clin. Cancer Res. 2009, 15(16), 5108–16.? ? T Taldone et al. Targeting Hsp90: small-molecule inhibitors and their clinical development. Cur. Opin. Pharmacol. 2008, 8(4), 370-374.? Certificate of Analysis Material Safety Data Sheet Apoptosis Cardiovascular Cell Cycle Regulation Cell Signaling & Oncology Hsp90 EC 3.6 Hsp90 inhibitor Chemical name 6-Chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine Parent CAS No. [848695-25-0] Order Size Unit Price Stock 5 mg €80.00 In Stock

產(chǎn)品價(jià)格

現(xiàn)貨詢價(jià)，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

CNF 2024 - BIIB 021

Based on 12 reference(s) in Google Scholar 9 10 12

Axon 1543

CAS [848695-25-0]

MF C14H15ClN6O
MW 318.76

Purity: 99%
Soluble in DMSO

CNF 2024

Description

Oral inhibitor of heat shock protein 90 (Hsp90) under clinical development

B B?ll et al. Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF-κB and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell–Mediated Cytotoxicity. Clin. Cancer Res. 2009, 15(16), 5108–16.?

T Taldone et al. Targeting Hsp90: small-molecule inhibitors and their clinical development. Cur. Opin. Pharmacol. 2008, 8(4), 370-374.?

Certificate of Analysis
Material Safety Data Sheet

Apoptosis Cardiovascular Cell Cycle Regulation Cell Signaling & Oncology Hsp90 EC 3.6

Hsp90 inhibitor

Chemical name

6-Chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine

Parent CAS No.

[848695-25-0]

產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>